- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05182190
Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults
Study Overview
Status
Conditions
Detailed Description
The 5 test treatments (white bread (negative control), whole black beans (positive control), and 3 different pasta formulations) will be administered randomly over five weeks. Meals will be combined with spaghetti sauce for a total available carbohydrate amount of 50g.
Venous blood samples will be collected for glucose and insulin analysis at time 0 (fasting) and at 30, 60, 90, 120, and 180 minutes post-treatment (timing of the post-treatment blood draws started at time 0 [post-treatment], which is when the participant starts consuming the treatment meal). Blood analysis was completed by a reputable biomarker diagnostics laboratory, Quest Diagnostics.
Anthropometric measures such as weight, height, waist circumference, and blood pressure were collected at screening and at the start of each test day. Thirteen hours before testing, participants consumed a standardized frozen meal to reduce the potential variation in glycemic responses on test day due to varying pre-evening dietary intakes. This control meal was selected by each participant before the start of the study. Each participant was provided the same frozen meal every time, since the subjects serve as their own controls. The day before test day, participants completed a 24 hour food recall, satiety, and gastrointestinal questionnaires. The morning of each test day participants completed the International Physical Activity Questionnaire (IPAQ), satiety, and gastrointestinal questionnaires.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Iowa
-
Ames, Iowa, United States, 50011
- Iowa State University, Food Science and Human Nutrition Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- normal blood glucose
- BMI between 20-29.9 kg/m2.
- Chronic health conditions, e.g., hypertension, gastrointestinal disease.
Exclusion Criteria:
- Weight changes of >10% of body weight within previous 6 months
- Pregnant or breastfeeding
- Allergy to peas, beans, lentils, tomatoes, gluten, or latex
- Unwillingness or inability to follow study protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Control - White bread
Commercial white bread in a 50 gram available carbohydrate dose
|
Toasted white bread
|
ACTIVE_COMPARATOR: Control - whole black beans
Whole boiled black beans (Zenith) in a 50 gram available carbohydrate dose
|
Whole boiled black beans with spaghetti sauce
|
EXPERIMENTAL: Knife Mill pasta
Heat treated black bean flour made with standard Knife Mill techniques
|
Black bean pasta (KM) with spaghetti sauce
|
EXPERIMENTAL: Combined pasta
Black bean flour with medium protein made with novel compression/decompression mill
|
Black bean pasta (Combo) with spaghetti sauce (medium protein flour)
|
EXPERIMENTAL: Cyclone pasta
Black bean flour with lower protein made with novel compression/decompression mill
|
Black bean pasta (Cyclone) with spaghetti sauce (low protein flour)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in baseline blood glucose over 3 hours (glycemic response)
Time Frame: Time 0 (fasting) then every 30 minutes for 3 hours
|
Venous blood samples were collected via venous catheter.
Whole blood samples were analyzed for glucose content and insulin at commercial laboratory.
|
Time 0 (fasting) then every 30 minutes for 3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in satiety sensation
Time Frame: Time 0 (fasting) then every 30 minutes for 3 hours
|
Satiety level measured using a visual analog scale (0-100) every 30 minutes postprandially.
A higher score indicates greater satiety.
|
Time 0 (fasting) then every 30 minutes for 3 hours
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose, High Blood
-
Wageningen University and ResearchCompletedGlucose, Low Blood | Glucose, High BloodNetherlands
-
Ingredion IncorporatedKGK Science Inc.CompletedGlucose, Low Blood | Glucose, High Blood | Meals
-
Transdermal Delivery Solutions CorpLangford Research Institute, Inc.Not yet recruitingGlucose, High BloodUnited States
-
University of CopenhagenTechnical University of DenmarkCompletedBlood Glucose, HighDenmark
-
Matthew GroutCompletedMood | Cognitive Performance | Glucose, Low Blood | Glucose, High BloodUnited Kingdom
-
Matthew GroutCompletedDiet Modification | Mood | Glucose, Low Blood | Glucose, High Blood
-
NestléCompletedGlucose, High Blood | Infant DevelopmentPhilippines
-
Dow University of Health SciencesCompletedCognitive Change | Blood Pressure | Blood Glucose, HighPakistan
-
Amorepacific CorporationCompletedBlood Glucose, HighKorea, Republic of
Clinical Trials on White bread
-
Organización Interprofesional Agroalimentaria de...Universidad de GranadaCompleted
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustCompleted
-
Paulic Meunerie SAInstitut Polytechnique UniLaSalleCompleted
-
Newcastle-upon-Tyne Hospitals NHS TrustBiotechnology and Biological Sciences Research CouncilCompleted
-
University College DublinActive, not recruitingGlucose Intolerance | Healthy Subjects | Postprandial Hyperglycemia | Glycemic Control | Diabetes Mellitus RiskIreland
-
Ohio State UniversityUSDA Beltsville Human Nutrition Research CenterActive, not recruitingInflammation | PreDiabetes | Endotoxemia | DysbiosisUnited States
-
Glycemic Index Laboratories, IncUniversity of Guelph; Guelph Research and Development Centre, Agriculture and...Completed
-
University of ReadingBiotechnology and Biological Sciences Research CouncilCompletedCardiovascular Risk FactorUnited Kingdom
-
National Pingtung University Science and TechnologyCompleted
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceCompletedBody Weight Changes | Dietary Modification | Gastrointestinal Microbiome | Bread | Hematologic TestsIsrael